HSIC Stock Analysis: Buy, Sell, or Hold?
HSIC - Henry Schein Inc
$72.70
0.60 (0.83%)
▲
5d:
-2.36%
30d:
-11.76%
90d:
-4.51%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 04, 2026
Smart Money Accumulation
HSIC is down 4.5% this week, but smart money is accumulating calls. Top strike: $70 2026-04-17 with 678 OI. Call ratio: 90% View Scanner →
Strength: 6.3/10
Get Alerted When HSIC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HSIC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: HSIC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$116.81
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$72.53
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HSIC is currently trading at $72.70, which is considered slightly low relative to its 30-day fair value range of $74.22 to $80.60. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.4) compared to its historical average (14.1). Remarkably, the market is currently pricing in an annual earnings decline of 4.3% over the next few years. This pessimistic expectation contrasts with the company's recent 13.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, HSIC is in a downtrend. The price is currently testing key support at $71.24. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: HSIC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $90.00 (+23.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HSIC is in a downtrend. The price is currently testing key support at $71.24. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: HSIC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $90.00 (+23.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$74.22 -
$80.60
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding HSIC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.8% below Wall St target ($90.00)
Fair Price Analysis
30-Day Fair Range
$74.22 -
$80.60
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$71.24
Resistance Level
$75.59
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.38
Wall Street Target
$90.00
(+23.8%)
Revenue Growth (YoY)
7.7%
Earnings Growth (YoY)
13.6%
Profit Margin
3.0%
Valuation Discount vs History
-4.3% cheaper
PE vs Historical
12.4 vs 14.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.3%
(market-implied from PE analysis)
1-Year Target
$69.57
(-4%)
2-Year Target
$66.58
(-8%)
3-Year Target
$63.72
(-12%)
3-Yr Target (if PE normalizes)
(PE: 12→14)
$72.57
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 10.3%)
$176.19
(+142%)
Base:
(SPY PE: 12.4, Growth: 10.3%)
$97.60
(+34%)
Bear:
(PE: 10.5, Growth: 10.3%)
$82.96
(+14%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 22.11 | Current EPS (TTM): $3.27
Bull Case
$142.54
(+91%)
Analyst growth 79.3%, PE expands to 24.3
Base Case
$129.58
(+74%)
Market implied 79.3%, PE stable at 22.1
Bear Case
$49.16
(-34%)
Severe decline -20.0%, PE contracts to 18.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.4 to 14.1
Stabilization Target:
$82.79
(+13.9%)
PE Expansion Potential:
+13.9%
Share & Embed Analysis
Last updated: March 30, 2026 5:57 PM ET
Data refreshes hourly during market hours. Next update: 6:57 PM
Data refreshes hourly during market hours. Next update: 6:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSIC showing a specific setup today?
Insider Activity (6 Months)
1
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Kurt P Kuehn
SELL
2844 shares
2026-03-10
Philip A Laskawy
SELL
2844 shares
2026-03-05
Mark E Mlotek
SELL
5925 shares
2026-03-04
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$998 | 61 BUY |
|
COR
Cencora Inc. |
BUY
17 analysts |
$410 | 59 HOLD |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$250 | 52 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 53 HOLD |
Advanced HSIC Option Strategies
Professional options setups generated by AI based on today's HSIC price and gamma walls.
